Patents Examined by Brian T. Gedeon
-
Patent number: 12290681Abstract: A method of treating a patient having overactive bladder symptoms by a combination of stimulation of the patient's saphenous nerve and the patient's posterior tibial nerve. The method uses a neurostimulator having a computer processor and a signal generator which generates a first stimulation signal which is used to target the patient's saphenous nerve and a second stimulation signal which is used to target the posterior tibial nerve of the patient in accordance with a treatment protocol. The neurostimulator sends the first and second electrical stimulation signals to respective stimulators which then transmit the respective electrical stimulation signals to the patient's saphenous nerve and the patient's posterior tibial nerve in accordance with the stimulation protocol. The first and second stimulators are positioned in locations on the body of the patient to effectively modulate the patient's saphenous nerve and posterior tibial nerve respectively.Type: GrantFiled: September 19, 2022Date of Patent: May 6, 2025Assignee: EBT Medical, Inc.Inventors: Paul B. Yoo, Michael Sasha John
-
Patent number: 12290309Abstract: Systems, delivery devices, and methods to treat to ablate, damage, or otherwise affect tissue. The treatment systems are capable of delivering a coolable ablation assembly that ablates targeted tissue without damaging non-targeted tissue. The coolable ablation assembly damages nerve tissue to temporarily or permanently decrease nervous system input. The system, delivery devices, and methods can damage tissue and manage scarring and stenosis.Type: GrantFiled: July 18, 2022Date of Patent: May 6, 2025Assignee: Nuvaira, Inc.Inventors: Steven C. Dimmer, Martin L. Mayse, Mark E. Deem, Hanson S. Gifford
-
Patent number: 12285616Abstract: Systems, devices, and methods for tracking and determining the motion of a cardiac implant is disclosed. The motion of the implant is determined by transmitting acoustic energy to a tissue location using an acoustic controller-transmitter comprising an array of acoustic transducers; wherein the implant is configured to convert the transmitted acoustic energy to electrical energy; and the tracking is achieved by determining the electrical energy delivered to the tissue throughout one or more cardiac cycles in order to create a motion profile of the cardiac implant.Type: GrantFiled: July 13, 2022Date of Patent: April 29, 2025Assignee: EBR SYSTEMS, INC.Inventor: N. Parker Willis
-
Patent number: 12285607Abstract: Provided are an optimal stimulation position combination determination method using a preset guide system, a server, and a computer program. The optimal stimulation position combination determination method using a preset guide system according to various embodiments of the present invention is executed by a computing device and includes: simulating electric stimulation for a brain of a subject by using a plurality of stimulation position according to a preset guide system; and determining an optimal stimulation position combination for applying the electric stimulation to the preset target point in the brain of the subject by using a simulation result of the electric stimulation.Type: GrantFiled: February 21, 2022Date of Patent: April 29, 2025Assignee: NEUROPHET Inc.Inventors: Dong Hyeon Kim, Bong Seok Ko
-
Patent number: 12263347Abstract: In a medical device system, a computer apparatus is configured to receive body surface electrical signals from an electrode apparatus including multiple external electrodes. The computing apparatus generates electrical dyssynchrony data from the body surface electrical signals during delivery of His bundle pacing pulses and identifies effective His bundle capture based on the electrical dyssynchrony data. The computing apparatus generates an indication of His bundle capture in response to identifying the effective His bundle capture.Type: GrantFiled: March 11, 2022Date of Patent: April 1, 2025Assignee: Medtronic, Inc.Inventor: Subham Ghosh
-
Patent number: 12257439Abstract: A leadless pacemaker device configured to provide for an intra-cardiac pacing, including: processing circuitry configured to generate ventricular pacing signals for stimulating ventricular tissue, and a reception device for receiving a sensing signal indicative of an atrial activity, wherein the processing circuitry is configured to detect an atrial event derived from said sensing signal, wherein the atrial event is a valid atrial sense event, where a series of atrial events lie within a range for a normal atrial rate, and/or when the atrial rate variability is within a certain range indicating a regular atrial rhythm, wherein in case a valid atrial sense event is detected, the processing circuitry is further configured to: determine ventricular pacing events according to atrial events, calculate ventricular-atrial time delays, determine a correction value based a measured time delay and the calculated time delay, and adjust the ventricular pacing timing based on the correction value.Type: GrantFiled: November 4, 2022Date of Patent: March 25, 2025Assignee: BIOTRONIK SE & Co. KGInventors: Kurt Swenson, Shayan Guhaniyogi, Ravi Kiran Kondama Reddy, Christopher Jones, Madeline Anne Midgett, R. Hollis Whittington
-
Patent number: 12251564Abstract: An illustrative cochlear implant system includes an electrode lead having an array of electrodes, a cochlear implant coupled with the electrode lead and configured to be implanted within a recipient together with the electrode lead, and a processing unit communicatively coupled to the cochlear implant. The processing unit is configured to direct the cochlear implant to apply stimulation to the recipient by way of the array of electrodes. The processing unit is further configured to detect, by way of one or more electrodes included in the array of electrodes, a cortical potential produced by the recipient. Based on the detected cortical potential, the processing unit is configured to determine a fitting parameter associated with the cochlear implant system. Corresponding systems and methods are also disclosed.Type: GrantFiled: October 23, 2020Date of Patent: March 18, 2025Assignee: Advanced Bionics AGInventors: Leonid M. Litvak, R. Tissa Karunasiri, Hannah A. Glick, Kanthaiah Koka, Chen Chen, Jason Galster
-
Patent number: 12239385Abstract: A tool adapter, consisting of an adapter arm having a proximal end terminating with a connection and a distal end having a circular coupling, the circular coupling having a center and defining an axis orthogonal to the circular coupling and passing through the center. The adapter also has a tool grip rotatingly connected to the circular coupling so as to permit rotation of the tool grip about the axis, the tool grip being configured to fixedly retain a tool along the axis.Type: GrantFiled: September 9, 2020Date of Patent: March 4, 2025Assignee: AUGMEDICS LTD.Inventors: Stuart Wolf, Nissan Elimelech, Tomer Gera
-
Patent number: 12239386Abstract: A treatment apparatus, a computer program, and a computer-readable medium for carrying out a method for determining a position of a laser focus of a laser beam of an eye surgical laser of a treatment apparatus by a control device of the treatment apparatus, in which the laser beam of the treatment apparatus is emitted into or onto a human or animal eye and in which at least two Purkinje images of the laser beam on the eye are captured by an optical capturing device of the treatment apparatus, and in which the position of the laser focus in or on the eye is determined by the control device considering the captured Purkinje images and considering an opening angle of the laser beam.Type: GrantFiled: May 26, 2021Date of Patent: March 4, 2025Assignee: SCHWIND EYE-TECH-SOLUTIONS GMBHInventor: Pascal Naubereit
-
Patent number: 12233267Abstract: An implantable medical device is configured determine a numerical value of a variable that is monitored by the implantable medical device and convert the numerical value to a data sequence of modulated electrical stimulation rate intervals. The implantable medical device delivers electrical stimulation pulses according to the data sequence of modulated stimulation rate intervals to cause a modulated rate of activation of excitable tissue of a patient corresponding to the modulated stimulation rate intervals. The modulated rate of activation is detectable by a rate monitor for demodulation to the numerical value of the monitored variable data value. In some examples, the implantable medical device is a pacemaker delivering cardiac pacing pulses according to modulated pacing rate intervals to cause a modulated heart rate of the patient detectable by a heart rate monitor for demodulation to the numerical value of the monitored variable.Type: GrantFiled: September 30, 2022Date of Patent: February 25, 2025Assignee: Medtronic, Inc.Inventors: Wade M. Demmer, Todd J. Sheldon
-
Patent number: 12233268Abstract: Embodiments herein relate to implantable medical devices including a power subunit with a first biocompatible electrically conductive shell configured for direct contact with an in vivo environment. In some embodiments a lithium anode can be disposed within the first biocompatible electrically conductive shell in direct electrical communication with a feedthrough pin, wherein the feedthrough pin is electrically isolated from the first biocompatible electrically conductive shell. A cathode can also be disposed within the first biocompatible electrically conductive shell and can be in direct electrical communication with the first biocompatible electrically conductive shell. The first biocompatible electrically conductive shell has a positive electrical potential. The implantable medical device further includes an electronics control subunit with a control circuit disposed within a second biocompatible electrically conductive shell. Other embodiments are included herein.Type: GrantFiled: October 12, 2022Date of Patent: February 25, 2025Assignee: Cardiac Pacemakers, Inc.Inventors: Troy Anthony Giese, Ignacio Chi, Michael J. Root, Larry Michael Killeen
-
Patent number: 12232802Abstract: The instant disclosure relates to electrophysiology catheters for tissue ablation within a cardiac muscle. In particular, the instant disclosure relates to an electrophysiology catheter that conforms to a shape of a pulmonary vein receiving ablation therapy for a cardiac arrhythmia and produces a consistent tissue ablation line along a length and circumference of the pulmonary venous tissue.Type: GrantFiled: June 25, 2021Date of Patent: February 25, 2025Assignee: St. Jude Medical, Cardiology Division, Inc.Inventor: Gregory K. Olson
-
Patent number: 12226172Abstract: Transducer-based systems can be configured to display a graphical representation of a transducer-based device, the graphical representation including graphical elements corresponding to transducers of the transducer-based device, and also including between graphical elements respectively associated with a set of the transducers and respectively associated with a region of space between the transducers of the transducer-based device. Selection of graphical elements and/or between graphical elements can cause activation of the set of transducers associated with the selected elements. Selection of a plurality of graphical elements and/or between graphical elements can cause visual display of a corresponding activation path in the graphical representation. Visual characteristics of graphical elements and between graphical elements can change based on an activation-status of the corresponding transducers.Type: GrantFiled: October 19, 2022Date of Patent: February 18, 2025Assignee: KARDIUM INC.Inventors: Jeffery Charles Brewster, Daniel Martin Reinders, Daniel Robert Weinkam
-
Patent number: 12214182Abstract: An implantable pump system is provided, suitable for use as a left ventricular assist device (LVAD) system, having an implantable pump, a battery, a controller, and a programmer. The implantable pump includes a flexible membrane coupled to an actuator assembly via a skirt that extends toward the inlet of the pump and curves to guide blood toward the outlet. The actuator assembly is magnetically engageable with electromagnetic coils, so that when the electromagnetic coils are energized, the actuator assembly causes wavelike undulations to propagate along the flexible membrane to propel blood from the inlet, across the skirt, and through the outlet of the implantable pump. The controller may be programmed by a programmer to operate at frequencies and duty cycles that mimic physiologic flow rates and pulsatility while operating in an efficient manner that avoids thrombus formation, hemolysis and/or platelet activation.Type: GrantFiled: September 7, 2022Date of Patent: February 4, 2025Assignee: CorWave SAInventors: Luc Polverelli, Leopold Maine, Carl N. Botterbusch, Silvere Lucquin, Jean-Baptiste Drevet, Adrien Guignabert, Patrick Meneroud, Alexandra Schmidt, Pier-Paolo Monticone
-
Patent number: 12214211Abstract: A medical treatment system includes a medical treatment device for monitoring and providing treatment to a patient and a companion device communicatively coupled to the medical treatment device. The medical treatment device may display case information including physiological information visually rendered from physiological sensor inputs in a first display format and transmit the case information and medical data to the companion device. The companion device may include a device interface having a display screen to accept user input instructions for the medical treatment device during a medical event. The companion device may process the case information and medical data received from the medical treatment device and also cause display, at the device interface, of multiple data display views in which each of the display views is selectable via a respective display view selection portion of the device interface.Type: GrantFiled: September 3, 2021Date of Patent: February 4, 2025Assignee: ZOLL Medical CorporationInventors: James P. O'Connor, Kristen B. McCarthy, Mark Weary, Brett B. Bonner, Dan E. Goldman, Martin F. Trew, Shannon L. Peterson, Denise R. Eizadkhah
-
Patent number: 12194300Abstract: At least some embodiments of the present disclosure are directed to systems and methods for managing sleep disordered breathing (e.g., obstructive sleep apnea) for a patient. A first implantable electrode delivers a first stimulation signal proximate to a first nerve of the patient to stimulate the first nerve and activate at least one first muscle for an upper airway dilation of the person. A second implantable electrode delivers a second stimulation signal proximate to a second nerve to stimulate the second nerve and activate at least one second muscle for a caudal tracheal traction for an upper airway of the person. A stimulation signal generator generates the first and second stimulation signals and coordinates the delivery of the first stimulation signal with the delivery of the second stimulation signal.Type: GrantFiled: June 13, 2024Date of Patent: January 14, 2025Assignee: Restora Medical, Inc.Inventor: Quan Ni
-
Patent number: 12194303Abstract: A pacemaker is configured to operate in an atrial synchronous ventricular pacing mode and, after expiration of a conduction check time interval, switch to an asynchronous ventricular pacing mode that includes setting a ventricular pacing interval to a base pacing rate interval. The pacemaker is further configured to determine when atrioventricular block detection criteria are satisfied during the asynchronous ventricular pacing mode and, responsive to the atrioventricular block detection criteria being satisfied, switch back to the atrial synchronous ventricular pacing mode.Type: GrantFiled: February 25, 2022Date of Patent: January 14, 2025Assignee: Medtronic, Inc.Inventors: Juliana E. Pronovici, James W. Busacker, Keelia M. Escalante, Vincent P. Ganion, Greggory R. Herr, Todd J. Sheldon, Vincent E. Splett
-
Patent number: 12179023Abstract: Systems and methods make possible the placement of one or more electrode leads in a tissue region for providing functional and/or therapeutic stimulation to tissue. The systems and methods are adapted to provide the relief of pain.Type: GrantFiled: August 11, 2022Date of Patent: December 31, 2024Assignee: SPR Therapeutics, Inc.Inventor: Joseph W. Boggs
-
Patent number: 12179026Abstract: Exemplary embodiments of this disclosure include apparatus, systems and methods utilizing a passive, power-efficient backscattering communication system that enables transmitting data wirelessly between implantable magnetoelectric (ME) devices and an external base station. Certain embodiments encode the transmitted data through modulating the resonance frequency of a ME film by digitally tuning its electric loading conditions.Type: GrantFiled: June 16, 2023Date of Patent: December 31, 2024Assignee: William Marsh Rice UniversityInventors: Jacob Robinson, Fatima Alrashdan, Kaiyuan Yang, Zhanghao Yu, Joshua Woods, Amanda Singer, Matthew Parker
-
Patent number: 12179019Abstract: Some embodiments include a system with a sensor with electrodes including an active electrode and a receiving electrode that is in physical contact with skin of a patient forming an electrical circuit with control electronics of a controller that can measure an electrical parameter using an active electrode and a receiving electrode within a closed loop electrical muscle stimulation system. A sense electrical pulse can be applied to the tissue using the sensor, an electrical parameter measured from the tissue, and a stimulation pulse applied to the tissue based at least in part on the measured electrical parameter. The stimulation is adjustably controlled by the controller to maintain a constant power output to the tissue based on the electrical parameter. A good is coupled to a computer readable medium configured to store usage data, the usage data relating to the patient's use of the good.Type: GrantFiled: September 20, 2021Date of Patent: December 31, 2024Assignee: Motive Health, Inc.Inventors: Struan Coleman, Calvin Domenico, Edison Gieswein, Jessica Paparella, Joshua Butters, Marlina Kessler, David Saar, Lee Knox